On ECHEMI
Home > Drugs > Second PHARMA Co., Ltd.
Second PHARMA Co., Ltd.
  • Founded in:

    2003-06-17
  • Country:

    China China
  • Address:

    No. 33, Weiwu Road, Shangyu Economic and Technological Development Zone, Hangzhou Bay, Zhejiang Province
  • Tax NO.:

    91330604751186571F
  • Registered Funds:

    80.12 million yuan
  • Email:

Related Drugs
Niacinamide
Name Description Content CAS NO. Registered Holders
Nicotinamide

Extract from the above information

More

Extract from the above information

98-92-0 12
Houttuynia cordata sodium
Name Description Content CAS NO. Registered Holders
Sodium houttufonate

Not clearly described

More

Not clearly described

0
Nicergoline
Nicergoline
Name Description Content CAS NO. Registered Holders
Nicergoline

Extract from the above information

More

Extract from the above information

27848-84-6 35
Isoniazid
Name Description Content CAS NO. Registered Holders
Isoniazid

Anti-TB drugs

More

Anti-TB drugs

54-85-3 20
niacin
niacin.
Name Description Content CAS NO. Registered Holders
Nicotinic acid

Nicotinic acid is converted into nicotinamide in the body, and then combined with riboadenin to form nicotinamide adenine dinucleotide (coenzyme I) and nicotinamide adenine dinucleotide phosphate (coenzyme II), which are necessary for lipid amino acid, protein, purine metabolism, tissue respiration oxidation and glycogenolysis. Nicotinic acid can reduce the utilization of coenzyme A; by inhibiting the synthesis of very low density lipoprotein (VLDL), it affects the transport of cholesterol in the blood. Large doses can reduce serum cholesterol and triglyceride concentrations. Nicotinic acid has a peripheral vasodilation effect.

More

Nicotinic acid is converted into nicotinamide in the body, and then combined with riboadenin to form nicotinamide adenine dinucleotide (coenzyme I) and nicotinamide adenine dinucleotide phosphate (coenzyme II), which are necessary for lipid amino acid, protein, purine metabolism, tissue respiration oxidation and glycogenolysis. Nicotinic acid can reduce the utilization of coenzyme A; by inhibiting the synthesis of very low density lipoprotein (VLDL), it affects the transport of cholesterol in the blood. Large doses can reduce serum cholesterol and triglyceride concentrations. Nicotinic acid has a peripheral vasodilation effect.

59-67-6 15
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.